Tags » Brilinta

Long-term use of AZ' Brilinta, ticagrelor gets US priority review

An application to use AstraZeneca’s Brilinta to treat patients with a history of heart attack has been placed on a fast track regulatory pathway in the US, meaning that approval could be granted within just six months. 183 more words

Priority Review

Facile [3+2] cycloaddition continuous flow strategies to triazolopyrimidines

A recent example of reaction route scouting was published by a group at Northeastern University ( J Flow Chem 2014, Graham Jones et al) showing several critical factors going into the azide cycloaddition chemistry in forming a desired triazole. 443 more words

US Department Of Justice Ends Investigation Of AstraZenca Trial

AstraZeneca announced today that the US Department of Justice has ended its investigation into alleged misconduct associated with the pivotal PLATO trial. The company said it had fully cooperated with the investigation, which began in October of 2013. 10 more words

Policy & Ethics